The Energy Biosciences Institute will be funded by a $500 million grant from BP over a 10-year period as well as smaller matching grants from California. Scientists at EBI will explore such issues as, transportation fuels produced out of or by microbes and that can be turned into transportation fuel.
Several universities sought to participate in program, which BP announced last June., Stanford University, and other universities have been expanding their energy and environmental engineering programs in recent years, and large, well-funded labs like the EBI can serve as a magnet for talented researchers worldwide. (Energy conglomerates, particularly petroleum companies, meanwhile, have complained about a in the field.)
The company selected the University of Illinois in part because of the school's strength in agronomy and biofuels. Berkeley, meanwhile, has become one of the centers for, a relatively new branch of genetics that involves exploiting natural processes for medical industrial use. Synthetic biologists combine genes from different animals to create a synthetic creature that secretes a desired chemical. They also try to reproduce naturally occurring chemicals inside a lab.
Jay Keasling, a Berkeley professor who runs the school's synthetic biology lab, for instance, has developed an antimalarial drug that can be made in a lab that is chemically identical to a naturally occurring, but hard to harvest, version of the same drug., a company founded on Keasling's research, is also working on developing synthetic microbes that can process sugars into transportation fuel. (John Melo, Amyris' CEO, also used to run BP's U.S. fuel operations and advised the worldwide CEO.)
Scientists from thewill also participate in the EBI. Both universities and the Lawrence Lab have also been principal players in some of the biggest technological breakthroughs in the U.S. in the past 50 years.
Some of the areas of research at the EBI will overlap with the Helios project, a $250 million alternative energy research program sponsored by the Department of Energy. Helios grants are being awarded nationwide.
Partly because BP is from Europe, where governments and citizens more actively pursue green policies, it has been one of the more aggressive oil companies when it comes to embracing alternative fuels.
"This program will further both basic and applied biological research relevant to energy. In short, it will create the discipline of energy biosciences. The institute will be unique in both its scale and its partnership between BP, academia and others in the private sector," BP Group Chief Executive John Browne said in a statement.